The Nordics

Participation in hospital procurement and tendering is not just an operational requirement, but a key aspect of pharmaceutical companies’ market access strategy. By engaging in…

Real-world evidence (RWE) has become increasingly visible in health technology assessment (HTA) discussions across Europe. In the Nordic countries, however, its role remains distinctive —…

Unlocking the Nordics: The Nordic countries may seem like small markets in terms of population, but their importance in pharmaceutical commercialization should not be underestimated.…